Home › Employers › HealthMark Medical Group, LLC
HealthMark Medical Group, LLC: H-1B salaries and sponsorship
HealthMark Medical Group, LLC filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $180,000.
Does HealthMark Medical Group, LLC sponsor H-1B visas?
HealthMark Medical Group, LLC filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Dec 8, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Senior Director, Interoperability | 1 | $180,000 |
| Lead Business Systems Analyst | 1 | $135,000 |
| Product Manager | 1 | $194,688 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $180,000 |
| FY2024 | 1 | $135,000 |
| FY2026 | 1 | $194,688 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Product Manager | $194,688 Level III | Detroit, MI | Dec 8, 2025 | Jun 1, 2026 | Certified |
| Lead Business Systems Analyst | $135,000–$145,000 Level III | Elkridge, MD | Oct 9, 2023 | Nov 1, 2023 | Certified |
| Senior Director, Interoperability | $180,000–$200,000 Level III | Detroit, MI | May 7, 2023 | Jun 1, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).